Neprilysin inhibitor–angiotensin II receptor blocker...

  • Main
  • 2020 / 04
  • Neprilysin inhibitor–angiotensin II receptor blocker...
European Heart Journal - Cardiovascular Pharmacotherapy 2020 / 04

Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients

Acanfora, Domenico, Ciccone, Marco Matteo, Scicchitano, Pietro, Acanfora, Chiara, Casucci, Gerardo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Heart Journal - Cardiovascular Pharmacotherapy
DOI:
10.1093/ehjcvp/pvaa028
Date:
April, 2020
File:
PDF, 236 KB
2020
Conversion to is in progress
Conversion to is failed